(Q39806478)

English

Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

thrombocytopenia

1 reference

based on heuristic

inferred from title

pathophysiology

1 reference

based on heuristic

inferred from title

thrombotic thrombocytopenic purpura

1 reference

based on heuristic

inferred from title

2

object named as

Elie Azoulay

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Agnès Veyradier

15

object named as

Agnès Veyradier

0 references

François Provôt

9

object named as

François Provôt

0 references

author name string

Eric Mariotte

1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Lionel Galicier

3

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Eric Rondeau

4

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Fouzia Zouiti

5

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Pierre Boisseau

6

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Pascale Poullin

7

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Emmanuel de Maistre

8

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

François Provôt

9

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Yahsou Delmas

10

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Pierre Perez

11

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Ygal Benhamou

12

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Alain Stepanian

13

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Paul Coppo

14

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Agnès Veyradier

15

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

French Reference Center for Thrombotic Microangiopathies

16

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

publication date

16 April 2016

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

The Lancet. Haematology.

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

e237-45

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930018-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930018-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930018-7

7 January 2021

based on heuristic

inferred from DOI database lookup

What's new in the diagnosis and pathophysiology of thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930018-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930018-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Animal models for thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930018-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930018-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930018-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930018-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival and relapse in patients with thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930018-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930018-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Regional UK TTP registry: correlation with laboratory ADAMTS 13 analysis and clinical features

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930018-7

7 January 2021

based on heuristic

inferred from DOI database lookup

ADAMTS-13 activity and autoantibodies classes and subclasses as prognostic predictors in acquired thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930018-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930018-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930018-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Registry of 919 patients with thrombotic microangiopathies across Japan: database of Nara Medical University during 1998-2008.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930018-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Acquired idiopathic ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in a population from Japan

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930018-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical features of severe acquired ADAMTS13 deficiency in thrombotic thrombocytopenic purpura: the Korean TTP registry experience

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930018-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Ten candidate ADAMTS13 mutations in six French families with congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome).

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930018-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history of Upshaw-Schulman syndrome based on ADAMTS13 gene analysis in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930018-7

7 January 2021

based on heuristic

inferred from DOI database lookup

FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930018-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930018-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930018-7

7 January 2021

based on heuristic

inferred from DOI database lookup

ADAMTS13 mutations and polymorphisms in congenital thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930018-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical features and prognostic factors of thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus: a literature review of 105 cases from 1999 to 2011.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930018-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR).

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930018-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Measurement and prevalence of circulating ADAMTS13-specific immune complexes in autoimmune thrombotic thrombocytopenic purpura.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930018-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930018-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The prognostic value of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats, member 13) deficiency in septic shock patients involves interleukin-6 and is not dependent on disseminated intravascular coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930018-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S2352-3026(16)30018-7

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39806478&oldid=2090634920"